Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WuXi Biologics to Build New Biologics Center | Contract Pharma
Breaking News

WuXi Biologics to Build New Biologics Center

48,000L mfg. facility will be one of the largest in northern China

WuXi Biologics has begun construction on a Biologics Manufacturing Center of excellence in the city of Shijiazhuang, a one hour train ride from Beijing.
 
The new Biologics Center will be equipped with 48,000L bioreactor capacity and will be built to meet cGMP standards of the U.S., EU and China. It will mark the eighth drug substance manufacturing facility of WuXi Biologics, which says it plans to have more than 220,000L total manufacturing capacity by 2021.
 
“We are pleased to break ground today and look forward to the operations of this new Biologics Center,” said said Dr. Chris Chen, chief executive officer, WuXi Biologics. “This facility will enable WuXi Biologics to develop and manufacture biologics more cost effectively as well as to provide a robust supply chain network for our global partners, and ultimately to benefit patients worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters